p53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients with Breast CancerYe Xu, Yuntao Xie, Lihua Yao et al.|Clinical Cancer Research|2005Cited by 102
<i>HER2</i> somatic mutations are associated with poor survival in HER2‐negative breast cancersTonghui Wang, Yuntao Xie, Ye Xu et al.|Cancer Science|2017Cited by 67
Association of <i>PIK3CA</i> Mutation Status before and after Neoadjuvant Chemotherapy with Response to Chemotherapy in Women with Breast CancerHua Yuan, Yuntao Xie, Jiuan Chen et al.|Clinical Cancer Research|2015Cited by 56
<i>RAD50</i> germline mutations are associated with poor survival in <i>BRCA1/2</i>–negative breast cancer patientsCong Fan, Yuntao Xie, Juan Zhang et al.|International Journal of Cancer|2018Cited by 45
Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor statusYe Xu, Yuntao Xie, Olle Larsson et al.|Breast Cancer Research and Treatment|2005Cited by 19